125 related articles for article (PubMed ID: 35931370)
1. Mitochondrial DNA content as a diagnostic marker for antituberculosis drug-induced liver injury.
Udomsinprasert W; Jittikoon J; Chaikledkaew U; Saengsiwaritt W; Chanhom N; Suvichapanich S; Wattanapokayakit S; Mahasirimongkol S; Chantratita W
Int J Infect Dis; 2022 Sep; 122():1034-1040. PubMed ID: 35931370
[TBL] [Abstract][Full Text] [Related]
2. Global DNA hypomethylation of Alu and LINE-1 transposable elements as an epigenetic biomarker of anti-tuberculosis drug-induced liver injury.
Udomsinprasert W; Sakuntasri W; Jittikoon J; Chaikledkaew U; Honsawek S; Chantratita W; Wattanapokayakit S; Mahasirimongkol S
Emerg Microbes Infect; 2021 Dec; 10(1):1862-1872. PubMed ID: 34467830
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte telomere length as a diagnostic biomarker for anti-tuberculosis drug-induced liver injury.
Udomsinprasert W; Chanhom N; Suvichapanich S; Wattanapokayakit S; Mahasirimongkol S; Chantratita W; Jittikoon J
Sci Rep; 2020 Mar; 10(1):5628. PubMed ID: 32221362
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, risk factors, management, and treatment outcomes of first-line antituberculous drug-induced liver injury: a prospective cohort study.
Sun Q; Zhang Q; Gu J; Sun WW; Wang P; Bai C; Xiao HP; Sha W
Pharmacoepidemiol Drug Saf; 2016 Aug; 25(8):908-17. PubMed ID: 26935778
[TBL] [Abstract][Full Text] [Related]
5. Association of POR and PPARα polymorphisms with risk of anti-tuberculosis drug-induced liver injury in Western Chinese Han population.
Zhang C; Jiao L; Bai H; Zhao Z; Hu X; Wang M; Wu T; Peng W; Liu T; Song J; Zhou J; Li M; Lyv M; Zhang J; Chen H; Chen J; Ying B
Infect Genet Evol; 2020 Apr; 79():104147. PubMed ID: 31857256
[TBL] [Abstract][Full Text] [Related]
6. The susceptibility of anti-tuberculosis drug-induced liver injury and chronic hepatitis C infection: A systematic review and meta-analysis.
Chang TE; Huang YS; Chang CH; Perng CL; Huang YH; Hou MC
J Chin Med Assoc; 2018 Feb; 81(2):111-118. PubMed ID: 29198550
[TBL] [Abstract][Full Text] [Related]
7. Chronic hepatitis B infection and risk of antituberculosis drug-induced liver injury: Systematic review and meta-analysis.
Wang NT; Huang YS; Lin MH; Huang B; Perng CL; Lin HC
J Chin Med Assoc; 2016 Jul; 79(7):368-74. PubMed ID: 27032895
[TBL] [Abstract][Full Text] [Related]
8. A prospective study on associations between superoxide dismutase gene polymorphisms and antituberculosis drug-induced liver injury in a Chinese Han population.
Wu T; Bai H; Zhao Z; Wang M; Hu X; Jiao L; Wu Q; Liu T; Zhang C; Chen H; Zhang J; Song J; Wu L; Zhou W; Tong C; Ying B
J Gene Med; 2019 Oct; 21(10):e3121. PubMed ID: 31415712
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of ALDH1A1 gene polymorphisms associated with antituberculosis drug-induced liver injury in western Chinese Han population.
Peng W; Zhao ZZ; Jiao L; Wu T; Chen H; Zhang CY; Song JJ; Liu TY; Wu LJ; Wang MJ; Chen J; Zhou Y; Ying BW
Microbiol Immunol; 2021 Apr; 65(4):143-153. PubMed ID: 33527427
[TBL] [Abstract][Full Text] [Related]
10. The association between cytochrome P450 polymorphisms and anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis.
Liu X; Ren S; Zhang J; Xu D; Jiang F; Jiang P; Feng J; Deng F
Ann Palliat Med; 2021 Jun; 10(6):6518-6534. PubMed ID: 34154362
[TBL] [Abstract][Full Text] [Related]
11. The genetic variants in calcium signaling related genes influence anti-tuberculosis drug induced liver injury: A prospective study.
Lyu M; Zhou J; Chen H; Bai H; Song J; Liu T; Cheng Y; Ying B
Medicine (Baltimore); 2019 Nov; 98(44):e17821. PubMed ID: 31689868
[TBL] [Abstract][Full Text] [Related]
12. Relationship between xanthine oxidase gene polymorphisms and anti-tuberculosis drug-induced liver injury in a Chinese population.
Ai X; Huang H; Miao Z; Zhou T; Wu H; Lai Y
Infect Genet Evol; 2021 Sep; 93():104991. PubMed ID: 34229066
[TBL] [Abstract][Full Text] [Related]
13.
Chanhom N; Wattanapokayakit S; Satproedprai N; Suvichapanich S; Mahasirimongkol S; Chaikledkaew U; Udomsinprasert W; Mushiroda T; Jittikoon J
Heliyon; 2021 Apr; 7(4):e06852. PubMed ID: 33981901
[TBL] [Abstract][Full Text] [Related]
14. Genetic Polymorphisms in Antioxidant Enzymes Modulate the Susceptibility of Idiosyncratic Antituberculous Drug-Induced Liver Injury and Treatment Outcomes in Patients with Tuberculosis.
Sun Q; Sha W; Liu HP; Wang P; Liu ZB; Sun WW; Xiao HP
Pharmacotherapy; 2020 Jan; 40(1):4-16. PubMed ID: 31742742
[TBL] [Abstract][Full Text] [Related]
15. NAT2 ultra-slow acetylator and risk of anti-tuberculosis drug-induced liver injury: a genotype-based meta-analysis.
Suvichapanich S; Fukunaga K; Zahroh H; Mushiroda T; Mahasirimongkol S; Toyo-Oka L; Chaikledkaew U; Jittikoon J; Yuliwulandari R; Yanai H; Wattanapokayakit S; Tokunaga K
Pharmacogenet Genomics; 2018 Jul; 28(7):167-176. PubMed ID: 29781872
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors of anti-tuberculosis drug induced liver injury (DILI): Large cohort study involving 4652 Chinese adult tuberculosis patients.
Jiang F; Yan H; Liang L; Du J; Jin S; Yang S; Wang H; Hu T; Zhu Y; Wang G; Hu Y; Cai T; Aithal GP
Liver Int; 2021 Jul; 41(7):1565-1575. PubMed ID: 33866661
[TBL] [Abstract][Full Text] [Related]
17. Genomewide Association Study Confirming the Association of
Suvichapanich S; Wattanapokayakit S; Mushiroda T; Yanai H; Chuchottawon C; Kantima T; Nedsuwan S; Suwankesawong W; Sonsupap C; Pannarunothai R; Tumpattanakul S; Bamrungram W; Chaiwong A; Mahasirimongkol S; Mameechai S; Panthong W; Klungtes N; Munsoo A; Chauychana U; Maneerat M; Fukunaga K; Omae Y; Tokunaga K
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109976
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury.
Zhang J; Zhao Z; Bai H; Wang M; Jiao L; Peng W; Wu T; Liu T; Chen H; Song X; Wu L; Hu X; Wu Q; Zhou J; Song J; Lyv M; Ying B
PLoS One; 2019; 14(9):e0222033. PubMed ID: 31490979
[TBL] [Abstract][Full Text] [Related]
19. Association of genetic polymorphisms of
Yang S; Hwang SJ; Park JY; Chung EK; Lee JI
BMJ Open; 2019 Aug; 9(8):e027940. PubMed ID: 31375612
[TBL] [Abstract][Full Text] [Related]
20. Meta-Analysis-Based Preliminary Exploration of the Connection between ATDILI and Schizophrenia by GSTM1/T1 Gene Polymorphisms.
Cai L; Cai MH; Wang MY; Xu YF; Chen WZ; Qin SY; Wan CL; He L
PLoS One; 2015; 10(6):e0128643. PubMed ID: 26046920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
